Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus

ClinicalTrials.gov ID: NCT00002546

Public ClinicalTrials.gov record NCT00002546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Study of Accelerated Hyperfractionated Whole Abdominal Radiotherapy (AHWAR) Versus Combination Ifosfamide-Mesna With Cisplatin in Optimally Debulked Stage I, II, III, or IV Carcinosarcoma (CS) of The Uterus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy is more effective than combination chemotherapy in treating patients with cancer of the uterus. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to combination chemotherapy in treating patients with cancer of the uterus.

Study identification

NCT ID
NCT00002546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
216 participants

Conditions and interventions

Conditions

Interventions

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
21 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1993 (Type not available)
Primary completion
Sep 2007 (Actual)
Completion
Not listed
Last update posted
Feb 11, 2016

Started 1993

United States locations

U.S. sites
64
U.S. states
31
U.S. cities
59
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
Women's Cancer Center - Los Gatos Los Gatos California 95032 —
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Rush University Medical Center Chicago Illinois 60612-3824 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
CCOP - Central Illinois Decatur Illinois 62794-9640 —
CCOP - Evanston Evanston Illinois 60201 —
Not listed Hinsdale Illinois 60521 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202-5289 —
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002 —
Cancer Center at Tufts - New England Medical Center Boston Massachusetts 02111 —
UMASS Memorial Cancer Center - University Campus Worcester Massachusetts 01605-2982 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Keesler Medical Center - Keesler Air Force Base Keesler Air Force Base Mississippi 39534-2576 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65807 —
Siteman Cancer Center at Barnes-Jewish Hospital St Louis Missouri 63110 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0002 —
Cancer Institute of New Jersey at the Cooper University Hospital Camden New Jersey 08103-1489 —
MBCCOP - University of New Mexico HSC Albuquerque New Mexico 87131 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11790-7775 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7570 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Gynecologic Oncology Network Greenville North Carolina 27858 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0526 —
MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland Ohio 44106 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio 43210-1240 —
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73104 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001-3788 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Abramson Cancer Center at the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 —
UPMC Cancer Center at Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Southeast Gynecologic Oncology Associates Knoxville Tennessee 37917 —
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-2516 —
University of Texas Medical Branch Galveston Texas 77555-0587 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus Burlington Vermont 05401 —
Cancer Center at the University of Virginia Charlottesville Virginia 22908 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109-1024 —
MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 11, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →